Numerai Gp LLC Ani Pharmaceuticals Inc Transaction History
Numerai Gp LLC
- $709 Billion
- Q3 2025
A detailed history of Numerai Gp LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Numerai Gp LLC holds 6,006 shares of ANIP stock, worth $504,624. This represents 0.08% of its overall portfolio holdings.
Number of Shares
6,006Holding current value
$504,624% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding ANIP
# of Institutions
288Shares Held
20MCall Options Held
30.6KPut Options Held
30.7K-
Black Rock Inc. New York, NY2.66MShares$223 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$110 Million0.0% of portfolio
-
State Street Corp Boston, MA712KShares$59.8 Million0.0% of portfolio
-
Global Alpha Capital Management Ltd.631KShares$53 Million3.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il580KShares$48.7 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.46B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...